Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
アンドロゲン受容体の標的分解のための化合物および方法
Document Type and Number:
Japanese Patent JP2023507570
Kind Code:
A
Abstract:
本開示は、化合物、その調製物、およびそれを必要とする対象における、転移性および／または去勢抵抗性前立腺癌を含む前立腺癌の治療における、これらの化合物の使用に関する。【選択図】なし

More Like This:
WO/2004/101523NOVEL 2-OXO-HETEROCYCLIC COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
JP3231834IMIDOCARBOXYLIC ACID ACTIVATOR, SULFIMIDOCARBOXYLIC ACID ACTIVATOR, THEIR PRODUCTION AND METHOD FOR USING THEM
WO/2018/0982046-MEMBERED URACIL ISOSTERES
Inventors:
Crew, Andrew Pea.
Don, Hunting
Snyder, Lawrence Bee.
Wan, Jin
Application Number:
JP2022537498A
Publication Date:
February 24, 2023
Filing Date:
December 18, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ARVINAS OPERATIONS, INC.
International Classes:
C07D211/88; A61K9/20; A61K31/165; A61K31/337; A61K31/4166; A61K31/496; A61K31/497; A61K31/501; A61K31/506; A61K31/5377; A61K31/5386; A61K31/539; A61K31/565; A61K31/57; A61K31/663; A61K31/675; A61K38/08; A61K45/00; A61P13/08; A61P35/00; C07D401/12; C07D401/14; C07D413/06; C07D413/12; C07D498/10
Attorney, Agent or Firm:
Shusaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto



 
Previous Patent: Benzodiazepine Derivatives, Compositions and Methods for Treating Cognitive Disorders

Next Patent: SOS1 inhibitor